avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Myf6
|
ENSMUSG00000035923.3 | myogenic factor 6 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Myf6 | mm10_v2_chr10_-_107494719_107494742 | -0.39 | 1.8e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.7 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
3.9 | 42.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
3.3 | 19.5 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
3.2 | 9.7 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
2.5 | 12.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
2.5 | 7.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
2.3 | 11.7 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
2.1 | 6.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.9 | 11.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.9 | 5.7 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.7 | 5.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.7 | 30.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.6 | 4.8 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.6 | 4.7 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.6 | 14.0 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
1.5 | 6.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.5 | 7.4 | GO:0009414 | response to water deprivation(GO:0009414) |
1.4 | 7.0 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.3 | 5.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.3 | 3.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.3 | 6.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.3 | 10.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.2 | 9.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.1 | 3.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.1 | 3.3 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
1.0 | 4.1 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.0 | 4.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.0 | 1.9 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
1.0 | 2.9 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
0.9 | 2.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 3.7 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.9 | 4.6 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.9 | 4.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.9 | 1.8 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
0.9 | 2.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.8 | 10.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.8 | 2.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.8 | 5.7 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 8.2 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.8 | 22.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.8 | 2.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 3.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.8 | 1.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.8 | 2.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.8 | 2.3 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.8 | 5.3 | GO:0015862 | uridine transport(GO:0015862) |
0.8 | 2.3 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.7 | 3.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.7 | 4.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 4.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 2.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.7 | 2.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.7 | 2.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.7 | 3.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 14.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.6 | 4.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 2.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 3.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.6 | 1.2 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.6 | 5.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 3.6 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.6 | 2.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 1.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.6 | 2.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 0.6 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 6.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.5 | 1.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 8.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 2.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 2.4 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.5 | 6.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 2.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.5 | 3.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 2.2 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 0.4 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.4 | 2.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.4 | 2.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 2.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 4.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 2.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 16.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.4 | 1.6 | GO:0009816 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.4 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 0.8 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.4 | 3.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.4 | 2.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.4 | 1.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 2.8 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.0 | GO:0060066 | oviduct development(GO:0060066) response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 13.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 6.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 1.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.3 | 1.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 1.0 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 1.0 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.3 | 1.3 | GO:0021660 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.3 | 3.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 5.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 3.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 2.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 3.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 1.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 3.2 | GO:0052697 | flavonoid metabolic process(GO:0009812) flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 2.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 0.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 5.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 1.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.3 | 4.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 3.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 2.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.3 | 2.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 5.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.8 | GO:1902868 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.3 | 2.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 9.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 0.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.3 | 2.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.8 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.3 | 0.8 | GO:0060220 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) negative regulation of immature T cell proliferation in thymus(GO:0033088) camera-type eye photoreceptor cell fate commitment(GO:0060220) |
0.3 | 0.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 1.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 3.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 2.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 2.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 1.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.2 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.2 | 3.3 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.2 | 1.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 2.9 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 | 2.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 1.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 3.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.3 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.2 | 3.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.8 | GO:0061056 | sclerotome development(GO:0061056) |
0.2 | 1.2 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 1.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.4 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.2 | 1.9 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.2 | 0.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.2 | 0.8 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 1.9 | GO:0098885 | maternal process involved in parturition(GO:0060137) modification of postsynaptic actin cytoskeleton(GO:0098885) |
0.2 | 0.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 1.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 2.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 1.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.9 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 0.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 1.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 2.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.8 | GO:0007320 | insemination(GO:0007320) |
0.2 | 2.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.6 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 2.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 0.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 3.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.6 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 2.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 1.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.8 | GO:1901907 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.6 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 | 1.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 2.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.8 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 4.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.8 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 1.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 2.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 1.0 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 4.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.5 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 2.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 2.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 1.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.3 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) activation of meiosis involved in egg activation(GO:0060466) |
0.1 | 0.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 1.1 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.3 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.1 | 2.0 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 4.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 1.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 5.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 1.0 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.1 | 1.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 2.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 2.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.1 | 6.8 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 3.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 1.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 1.0 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 1.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:2000646 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 1.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 2.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 2.8 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) noradrenergic neuron development(GO:0003358) |
0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 1.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 1.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 1.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 1.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 2.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 2.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 3.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 1.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 2.2 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 2.8 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.9 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.5 | GO:0030953 | positive regulation of centrosome duplication(GO:0010825) astral microtubule organization(GO:0030953) |
0.0 | 1.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 1.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 2.4 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 1.6 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 6.3 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.0 | 0.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 5.5 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 2.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 1.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 1.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.7 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 4.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 1.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.0 | 1.9 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 1.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 3.3 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 1.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 1.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.2 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 1.4 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 3.2 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.0 | 0.0 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 1.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.8 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 2.4 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 1.0 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.8 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.9 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.4 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 25.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.7 | 8.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.2 | 19.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.9 | 24.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.9 | 22.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.6 | 6.4 | GO:0060187 | cell pole(GO:0060187) |
1.1 | 3.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.0 | 3.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 6.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.8 | 2.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.7 | 9.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 1.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.6 | 12.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.6 | 4.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 7.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.6 | 2.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 1.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.5 | 9.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.5 | 1.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.5 | 3.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 9.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.4 | 1.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 6.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 2.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 1.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 1.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.2 | GO:0044307 | dendritic branch(GO:0044307) |
0.3 | 3.3 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.3 | 7.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.7 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 11.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 2.2 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 2.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.9 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 3.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.8 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 4.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 2.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.6 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 2.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 1.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.2 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 2.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.6 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.1 | 6.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 2.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 4.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 3.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 2.1 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.0 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.1 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 2.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.9 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 3.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.4 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.1 | 2.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 2.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 6.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 2.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 3.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 1.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 2.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 2.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 2.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 5.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 3.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 2.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 8.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 3.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 8.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 4.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.0 | 10.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.9 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 15.5 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 7.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.9 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 2.1 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 1.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 1.0 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 2.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.3 | GO:0005009 | insulin-activated receptor activity(GO:0005009) pheromone activity(GO:0005186) |
2.7 | 8.2 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
2.0 | 6.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
2.0 | 14.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.9 | 24.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.8 | 17.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.6 | 4.8 | GO:0045159 | myosin II binding(GO:0045159) |
1.3 | 10.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.3 | 6.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.2 | 3.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.2 | 3.6 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
1.2 | 8.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 5.8 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 5.2 | GO:0032810 | sterol response element binding(GO:0032810) |
1.0 | 3.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.0 | 7.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.0 | 23.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.8 | 5.7 | GO:0002054 | nucleobase binding(GO:0002054) hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.8 | 3.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.8 | 18.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.7 | 13.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.7 | 9.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 10.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.7 | 2.8 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.7 | 4.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.6 | 4.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 12.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.6 | 2.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.6 | 22.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 3.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.6 | 3.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 1.8 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.6 | 1.7 | GO:0030350 | iron-responsive element binding(GO:0030350) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.6 | 3.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 4.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.5 | 2.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 1.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.5 | 2.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 1.4 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.5 | 2.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 2.2 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 2.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 2.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.4 | 2.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) NADH pyrophosphatase activity(GO:0035529) |
0.4 | 1.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 1.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.4 | 2.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 2.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 0.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 6.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 1.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 1.8 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.4 | 3.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 3.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 1.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 2.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 1.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 12.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 1.0 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.3 | 1.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.2 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.3 | 14.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 2.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 5.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 4.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 3.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.3 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.2 | 4.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 7.4 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 14.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 4.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.8 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.2 | 2.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 2.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 1.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 2.7 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.8 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 3.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 4.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 5.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.7 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 7.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 1.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 3.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 3.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 2.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 3.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 3.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 5.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 1.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 3.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 3.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 5.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 2.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.8 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 3.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 2.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 1.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 3.0 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 2.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 1.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 2.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 8.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 3.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 2.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 2.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 2.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 2.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 2.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 2.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 3.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.5 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 2.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0051431 | histone deacetylase regulator activity(GO:0035033) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 5.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 1.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.7 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 3.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 16.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 1.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 5.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 2.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 2.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 18.2 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 3.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.8 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.3 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 1.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.6 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 2.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 1.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.0 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 1.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0071074 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 2.1 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 1.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 1.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 6.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 1.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 4.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 1.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 14.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 9.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 3.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 22.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 21.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 16.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 2.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 7.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 10.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 6.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 10.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 9.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 5.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 1.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 3.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 6.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.0 | 29.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.0 | 12.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.0 | 13.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.7 | 6.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 5.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 11.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 9.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 19.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 5.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 8.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 4.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 8.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 34.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 3.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 4.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 5.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 4.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 4.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 2.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 3.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 3.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 7.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 3.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 8.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 1.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 3.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 1.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 3.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 3.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 5.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 4.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 7.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 6.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 2.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 3.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 2.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 5.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 9.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 2.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 1.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 2.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 8.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.6 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 2.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 1.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 2.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |